King Introduces Bicameral Legislation to Prohibit Pharmaceutical Drug Advertising
July 26, 2024
July 26, 2024
WASHINGTON, July 26 -- Sen. Angus S. King Jr., I-Maine, issued the following news release:
Senator Angus King (I-ME) is introducing legislation with Congresswoman Rosa DeLauro (D-CT) to prohibit direct-to-consumer advertising of pharmaceutical drugs. The Responsibility in Drug Advertising Act would prohibit direct-to-consumer (DTC) advertising of a new drug in the first three years after the drug receives Federal Drug Administration (FDA) approval. The FDA could waive the third year . . .
Senator Angus King (I-ME) is introducing legislation with Congresswoman Rosa DeLauro (D-CT) to prohibit direct-to-consumer advertising of pharmaceutical drugs. The Responsibility in Drug Advertising Act would prohibit direct-to-consumer (DTC) advertising of a new drug in the first three years after the drug receives Federal Drug Administration (FDA) approval. The FDA could waive the third year . . .